|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
PRTA | Zago Wagner M. | Chief Scientific Officer | Aug 02 | Option Exercise | 12.15 | 4,000 | 48,600 | 4,000 | Aug 02 09:00 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Aug 02 | Sale | 67.05 | 4,000 | 268,182 | 0 | Aug 02 09:00 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Jul 05 | Option Exercise | 12.15 | 4,000 | 48,600 | 4,000 | Jul 05 09:32 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Jul 05 | Sale | 68.16 | 4,000 | 272,648 | 0 | Jul 05 09:32 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Jun 07 | Option Exercise | 26.09 | 19,000 | 495,750 | 19,000 | Jun 07 09:49 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Jun 07 | Sale | 71.06 | 19,000 | 1,350,224 | 0 | Jun 07 09:49 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Jun 22 | Option Exercise | 17.81 | 115,250 | 2,052,940 | 115,250 | Jun 24 04:38 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Jun 22 | Sale | 46.15 | 115,250 | 5,318,769 | 0 | Jun 24 04:38 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Feb 18 | Option Exercise | 6.41 | 7,540 | 48,331 | 7,540 | Feb 19 06:39 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Feb 18 | Sale | 25.50 | 7,540 | 192,270 | 0 | Feb 19 06:39 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Feb 12 | Option Exercise | 11.48 | 26,310 | 302,147 | 18,750 | Feb 17 06:47 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Feb 12 | Sale | 19.16 | 26,310 | 504,057 | 0 | Feb 17 06:47 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Sep 28 | Option Exercise | 6.41 | 900 | 5,769 | 900 | Sep 29 05:15 PM |
PRTA | Zago Wagner M. | Chief Scientific Officer | Sep 28 | Sale | 70.00 | 900 | 63,000 | 0 | Sep 29 05:15 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite